The GLP is committed to full transparency. Download and review our 2019 Annual Report

Why we should be concerned about antibiotic-resistant superbugs

| | March 11, 2015

This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Scientists and public-health officials are a careful bunch who don’t often paint doomsday scenarios. That is, unless they’re talking about the issue of antibiotic resistance. More and more, as we learn that the threat of drug-resistant superbugs could literally spell our end, antibiotic resistance has become a worry akin to climate change: an overwhelming but intangible menace that can be difficult to rally around.

In recent years, this misuse has sped up the natural process of resistance, rendering some antibiotics useless and causing experts to warn that we are at the “dawn of a post-antibiotic era” that amounts to a health “nightmare” and “catastrophic threat” on par with terrorism. For example, in the US alone antibiotic-resistant infections are associated with 23,000 deaths and 2 million illnesses every year.

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend